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a b s t r a c t
In a one-year (October 2014eOctober 2015) pilot study, we assessed wastewater monitoring with sus-
tained sampling for analysis of global enterovirus (EV) infections in an urban community. Wastewater
was analysed by ultra-deep sequencing (UDS) after PCR ampliﬁcation of the partial VP1 capsid protein
gene. The nucleotide sequence analysis showed an unprecedented diversity of 48 EV types within the
community, which were assigned to the taxonomic species A (n¼ 13), B (n¼ 23), and C (n¼ 12). During
the same period, 26 EV types, of which 22 were detected in wastewater, were identiﬁed in patients
referred to the teaching hospital serving the same urban population. Wastewater surveillance detected a
silent circulation of 26 EV types including viruses reported in clinically rare respiratory diseases.
Wastewater monitoring as a supplementary procedure can complement clinical surveillance of severe
diseases related to non-polio EVs and contribute to the ﬁnal stages of poliomyelitis eradication.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Enteroviruses (EVs) are small, non-enveloped RNA viruses
within the Picornaviridae family. EVs involved in human infections
include polioviruses (PVs, n¼ 3), coxsackieviruses (CVs) A (n¼ 21)
and B (n¼ 6), echoviruses (Es, n¼ 29) and 49 other types
numbered 68e121 which are grouped among four taxonomic
species EV-A to EV-D. EV-B types are the most frequent causes of
aseptic meningitis outbreaks and have been occasionally reported
in other central nervous system syndromes (Mirand et al., 2008).
Several EV types have been observed in sporadic encephalitis cases,
in particular, infections caused by EV-A71, that are marked by
utmost severity (Xing et al., 2014).
The analysis of environmental and wastewater samples
collected from deﬁned communities has been used to estimate the
prevalence of speciﬁc enteric pathogens in populations for which
no clinical data are available, including EVs (Berchenko et al., 2017).
The World Health Organization has included environmental PV
surveillance in the new Strategic Plan of the Global Polio Eradica-
tion Initiative as a supplement to the surveillance of acute ﬂaccid
paralysis (AFP) (Polio Eradication & Endgame Strategic Plan,
2013e2018, 2013). Environmental surveillance has detected in-
fections with wild or vaccine-derived recombinant PVs without
observation of paralysis cases and the early introduction of virulent
strains within communities (Cowger et al., 2017; Manor et al.,
2014). As circulation of wild PVs has been virtually interrupted,
poliomyelitis is becoming a rare cause of AFP worldwide
(Tangermann et al., 2017). However, non-polio EVs are increasingly
reported in diseases with similar manifestations. In this respect, the
EV types EV-A71 and EV-D68 have emerged as a growing cause of
concern in children (Casas-Alba et al., 2017; Holm-Hansen et al.,
2016). Most EVs replicate in the small intestine mucosa and are
excreted in the faeces for 3e4 weeks, regardless of whether in-
fections are symptomatic or not. Health risks to susceptible in-
dividuals can stem from poor sanitation and the release of
untreated or inadequately treated wastewater efﬂuents, which
* Corresponding author. CHU Clermont-Ferrand, Laboratoire de Virologie, Centre
National de R!ef!erence des Ent!erovirus-Parechovirus e Laboratoire associ!e,
Clermont-Ferrand, France.
E-mail address: mbisseux@chu-clermontferrand.fr (M. Bisseux).
Contents lists available at ScienceDirect
Water Research
journal homepage: www.elsevier .com/locate/watres
https://doi.org/10.1016/j.watres.2019.115246
0043-1354/© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Water Research 169 (2020) 115246
increase the risk of exposure to disease-causing EVs and virus
transmission in the community. Accordingly, systematic environ-
mental sampling could provide important supplementary surveil-
lance data for non-polio EVs (Adeniji and Faleye, 2014).
We previously performed studies combining surveillance of
clinical EV manifestations and virological data to investigate the
epidemiologic patterns of EV diseases in France (Antona et al., 2016;
Lang et al., 2014; Mirand et al., 2016, 2010, 2008). In other studies,
we recorded changing patterns of several EV types each year among
patients ﬁnding a wide genetic diversity of virus lineages within a
same epidemic EV type and described the circulation of EV strains
between countries (Hassel et al., 2017, 2015; Henquell et al., 2013;
Othman et al., 2015). The ﬁndings suggested that susceptible in-
dividuals are exposed to a wide array of EV strains and that the
epidemiological patterns of clinical manifestations are driven by
constant ﬂows of virus strains from different countries, regardless
of whether they are neighbouring or distant countries. We hy-
pothesized that yearly outbreaks caused by a given EV type result
not only from the transmission of one epidemic virus strain within
the community but also from the exposure of individuals to mul-
tiple viruses of distinct lineages and geographic origins.
To investigate how environmental surveillance could be
implemented to complement clinical surveillance and improve
public health monitoring and evaluation, we performed a one-year
pilot study of municipal wastewater efﬂuents of the city of
Clermont-Ferrand, France, to analyse enteric infections (Bisseux
et al., 2018). In the present study, we analysed wastewater sam-
ples by ultra-deep sequencing (UDS) to determine the pattern of EV
infections of the whole community and compared the data with
those derived from clinical surveillance of the same population and
the entire French population. We discuss the relevance and limi-
tations of the present pilot study and the lessons learnt in terms of
epidemiologic surveillance and future applications.
2. Material and methods
2.1. Wastewater sampling and virus concentration
Sampling procedure and virus concentration steps have been
previously described (Bisseux et al., 2018). Brieﬂy, from October
2014 to October 2015, we sampled 20 L of raw wastewater every
2weeks at the wastewater treatment plant (WWTP) of the urban
area of Clermont-Ferrand that currently treats thewaste of 250,000
people. A total of 27 samples were collected from the inﬂuent of
WWTP. They were immediately ﬁltered under gravity through a
50 mm ﬁlter and transferred to the laboratory within 1 h after
collection. After a second gravity ﬁltration stage (20 mm), samples
were concentrated by tangential ﬂow ultraﬁltration using a hallow
ﬁbre ﬁlter (molecular cut-off 30 kDa, inner diameter 200 mm) and a
transmembrane pressure of 0.07e0.1 bar. After the addition of
10mM sodium pyrophosphate decahydrate and sonication, sam-
ples were centrifuged at 8,000 x g for 20min. The pH of superna-
tants was neutralised to pH 7. Virus precipitation was further
performed with polyethylene glycol (PEG). PEG 8000 and sodium
chloride were added to the supernatant at a ﬁnal concentration of,
respectively, 10% and 0.6% (w/v) and incubated at 4 "C for 24e48 h.
The white phase containing viruses was centrifuged at 8,000 x g at
4 "C for 20min. Pellets were suspended in buffer (0.1M NaCl, 8mM
MsSO-7H2O, 50mMTris-HCl and 0.005% (w/v) glycerol, pH 7). After
addition of 1M KCl, the mixture was incubated on ice for 40min to
precipitate PEG, leaving puriﬁed virus particles in suspension. After
centrifugation (12,000 x g, 10min at 4 "C), the supernatant was
stored at #20 "C. The raw wastewater samples were concentrated
to an average of 60mL (concentration factor: 333). Total nucleic
acids were extracted from 1mL of viral concentrates with the
NucliSENS® EasyMAG® platform (bioM!erieux, Marcy l’Etoile,
France), and eluates were immediately aliquoted and stored
at #80 "C until analysis.
2.2. Target gene ampliﬁcation and deep-sequencing
All the 27 samples tested positive for EV ARN (Enter-
ovirus@ceeram, bioM!erieux, France) and quantiﬁed as previously
reported (Bisseux et al., 2018) with an in-house assay (Volle et al.,
2012), and were subjected to deep sequencing. Two manipulators
in two distant laboratories performed all reactions in duplicate
independently following standard precautions to prevent PCR
contamination. The partial gene (360e390 nucleotides) encoding
the major VP1 capsid proteinwas ampliﬁed with pan-EV RT-nested
PCR (Nix et al., 2006). After the ﬁrst ampliﬁcation (40 cycles, ﬁrst
set of Nix primers), the second round (40 cycles) used the second
set of Nix primers tagged with a single sequence of eight nucleo-
tides for each replicate of each sample.
The positive control was a stool collected from a healthy child
containing a mixture of echovirus 13 (E#13) and coxsackievirus A2
(CV-A2), identiﬁed in a speciﬁc Illumina sequencing run. The
negative control was DNA- and RNA-free sterile water.
PCR products and controls were checked on standard 1% agarose
gel and puriﬁed with the MinElute® gel extraction kit (Qiagen,
Paris, France). All puriﬁed DNA samples were quantiﬁed with Agi-
lent D1000 Screen Tape system and mixed in the same quantity.
Sequencing was performed with the Illumina MiSeq sequencing
platform, which uses 2 x 300 bp paired-end chemistry at the GATC
platform, Germany. The sequencing run contained 58 tagged
amplicons from 27 WWTP samples, the positive and negative
controls, all in duplicate.
2.3. Reference databases for EV identiﬁcation from partial 1DVP1
Two different databases were built for the bio-informatics
analysis. The ﬁrst database, named database I, was built by align-
ing sequences from all human and non-human EV reference strains
downloaded from the NCBI GenBank database. Sequences of
Sapelovirus were added as an outgroup. The second database
(database II) was built to span intratypic EV diversity. The partial
VP1 gene sequences targeted by the PCR primers used in this study
were recovered from all nucleotide sequences for each human EV
type available in GenBank (as of March 2015). These published
sequences were compiled with those determined in our laboratory.
All the sequence data sets were constructed with the BioEdit soft-
ware version 7.1.9 (http://www.mbio.ncsu.edu/bioedit/bioedit.
html). Assignment and sequence quality were checked with
phylogenetic trees reconstructed by the neighbour joining method
implemented in MEGA software v5.01 (Tamura et al., 2011). The
sequences with assignment error or with suspected sequencing
error were discarded. For each type, we selected sequences repre-
senting each cluster (deﬁned as sequences with less than 1% of
nucleic acid differences). The ﬁnal database contained 3,256.
2.4. Bioinformatic analysis and quality control of sequence data
The VSEARCH open source tool for metagenomics (https://
github.com/torognes/vsearch) was used for processing and pre-
paring sequence data. After assembly of paired-end reads, se-
quences were aligned and those containing ambiguous bases (N) or
mismatches in primers were removed. Putative chimaeras were
identiﬁed and removed with the VSEARCH tool. The remaining
sequences that shared >98% nucleotide sequence identity were
assigned to a single operational taxonomic unit (OTU). The taxo-
nomic assignment of the sequence representing each OTU was
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performed by similarity and phylogeny using the two reference
databases described above. For each OTU, the closest sequences in
database II were selected by similarity for a ﬁrst assignment. These
sequences were then added to the phylogenetic tree reconstructed
with FastTree (Price et al., 2010) from sequences of database I for a
second phylogenetic assignment. The consistency of the results
provided by the two methods was veriﬁed. This process was per-
formed with a modiﬁed version of the pipeline PANAM (Phyloge-
netic Analysis of Next-generation AMplicons https://github.com/
panammeb/) (Taib et al., 2013). We checked the data for detecting
eventual mistagging effect (Esling et al., 2015; Schnell et al., 2015).
By removing sequences representing less 0.5% of the total abun-
dance, we eliminated the spurious ones (Technical appendix A,
supplementary data). Duplicates were then pooled for the ﬁnal
analysis. We normalised the WWTP samples using the vegan
package of R software, which consists in a random selection of the
same number of sequences in each sample. This number was
deﬁned as the number of sequences present in the sample con-
taining the lowest sequence number (16,250 sequences in our run).
2.5. EV sequences from clinical infections over the same period
Between October 2014 and October 2015, 3191 EV infections
were reported to the French national laboratory network of
enterovirus surveillance (RSE), coordinated by the Agency Sant!e
publique France and the National Reference Centre for enterovi-
ruses and parechoviruses. EVs were detected by molecular typing
in 2124 patients, of whom 122were seen at the teaching hospital of
Clermont-Ferrand. Typing was performed prospectively in all
clinical samples (cerebrospinal ﬂuid [CSF], blood, respiratory, stool
and throat). Nucleotide sequences were obtained after complete
VP1 gene ampliﬁcation with species speciﬁc primers (Mirand et al.,
2016, 2006; Schuffenecker et al., 2016) or with pan-EV primers (Nix
et al., 2006) targeting a partial region of the VP1 gene. The ampli-
cons were sequenced by the Sanger technique using the BigDye
Terminator kit (Applied Biosystems).
2.6. Phylogenetic analysis
Phylogenetic analysis based on the partial VP1 gene sequences
was performed with the maximum parsimony method imple-
mented in the Bionumerics software (bioM!erieux, Marcy l’Etoile,
France). The sequences that shared $98% nucleotide identity were
clustered in a single sphere.
2.7. Accession numbers
The partial VP1 gene sequences have been deposited in the
GenBank sequence database under accession numbers MK086267
to MK086510 and MK086163 to MK086266 for wastewater (OTUs)
and clinical sequences, respectively.
3. Results
3.1. Sequencing data
Of the merged sequences (assembly of forward and reverse
reads), 33% were discarded by the quality control analyses. Of the
remaining sequences assigned to an EV type, 0.4% were removed
because of incorrect or inaccurate assignment. The sequences
assigned to rhinovirus types (0.7%) were also excluded, leaving a set
of 2,001,179 sequences for further analyses. The cleaning analyses
applied to the entire dataset left 1,546,641 sequences in the
wastewater samples and 438,750 sequences after the normal-
isation of data (Table 1).
3.2. Diversity of EV types in the WWTP samples
OTUs were assigned to 3 taxonomic species EV-A, B and C
(Table 1). No sequences were allocated to the EV-D species. A total
of 48 EV types were detected in the wastewater samples. Among
them, 15 types (CV-A1, A11, A13, A19, A20, and A22, EV-A76, A89,
A90, A119, EV-B78, EV-C99, C105, C109, and C116) are rarely re-
ported in the clinical setting at a national level. Some, such as EV-
A119 and EV-A76, were detected sporadically in the wastewater
samples and others, such as CV-A11 and CV-A22, were present over
time in several consecutive samples. A set of 16 sequences clustered
in a single OTU and shared 99.4% nucleotide identity with the Sabin
PV-1 vaccine sequence (accession number V01150.1) and accord-
ingly were classiﬁed as Sabin-like PV-1.
After cleaning and normalisation, sequences were clustered into
180 OTUs, which were assigned to 33 EV types (Table 1). The se-
quences were distributed among EV-B (60.1%), EV-A (26%) and EV-C
(13.9%) species. Four EV types accounted for more than 70% of all
normalised sequences (Table 1): CV-B5 (43.9% of sequences), CV-
A16 (13.3%), CV-A5 (7.4%), and CV-A11 (6.2%). A set of 10 minority
EV types accounted for 1.5% of all sequences. Fifteen EV types
represented by a handful of sequences (less than 0.5% of the se-
quences from a respective sample; 2 to 703 sequences by type in
the whole sequence set) were removed during mistagging cleaning
and were excluded from the temporal analysis because their allo-
cation to a given sampling date was unreliable. However, they were
included in the analysis of the global diversity of EVs within the
community during the study period (Table 1).
3.3. Distribution of EV types in the clinical samples tested over the
study period
From October 2014 to October 2015, 126 patients (median
age¼ 3.07 years [range 4 dayse53.8 years]) referred to the teaching
hospital of Clermont-Ferrand had an EV infection, mainly menin-
gitis (Table 2). The 26 EV types identiﬁed in these patients were
distributed among EV-A (n¼ 7), EV-B (n¼ 15), EV-C (n¼ 3) and EV-
D (n¼ 1) species (Table 3). The two most frequent EV types were
CV-B5 and EV-D68. CV-B5 was detected in 30 patients and was
responsible for 15/52 (28.5%) meningitis cases observed during the
summer of 2015. EV-D68 (n¼ 17 patients), a cause of severe res-
piratory syndromes, was recorded only in October and November
2014. E#25, the third EV type, was reported in eight patients. The
EV types identiﬁed in stools during systematic examination for
adoption were EV-A120, CV-B5, CV-A13, and EV-C99.
During the same period, members of the EV surveillance na-
tional network (excluding the Clermont-Ferrand reporting site)
reported 45 types, which were assigned to EV-A (n¼ 8), EV-B
(n¼ 28), EV-C (n¼ 8) and EV-D (n¼ 1) species (unpublished
data). The overall EV-B species accounted for 1643 (82%) infections
reported in France, followed by EV-A (n¼ 172 infections, 8.6%), EV-
D (n¼ 165, 8.2%) and EV-C (n¼ 22, 1%) species.The three most
frequent EV types reported in France during 2014e2015 were E6
(18.6%), CV-B5 (14.5%), and EV-D68 (8.2%).
3.4. Comparison of EV types detected by clinical and environmental
surveillance
Over the study period, 48 EV types were detected in wastewater
and 26 in patients referred to the teaching hospital of Clermont-
Ferrand (Fig. 1). Of the 26 types identiﬁed in the patients, 22
(85%) were detected in wastewater. More than half (13/22, 60%)
were assigned to species B. The EV types EV-A120, EV-D68, E#7 and
E#13 were detected only by clinical surveillance and 26 types only
by environmental surveillance.
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Phylogenetic analysis showed high intra-type genetic diversity,
a pattern indicating that multiple viral lineages co-circulated
within the community (Fig. 2). High genetic diversity was
observed for the CV-B5 and CV-A6 types, both of which were
detected in wastewater and patients, and for other types detected
only in wastewater (e.g. CV-A11). Most viral sequences (54%)
recorded in patients clustered with wastewater OTUs, evidence of
close genetic relationships between viruses within the community
and those detected in patients. Marked differences were observed
among EV types in the genetic clustering rate of clinical sequences
with wastewater OTUs. This rate ranged from 0% (CV-A2, E#6, and
E#25) to 75% (CV-A6) and 100% (E#11). The CV-B5 sequences
Table 1
Detection of EV types in wastewater and evolution of their abundance in the successive steps of the bio-informatics analysis.
species types before mistagging detection after mistagging cleaning after data normalisation
sequences (n) sequences (%) OTUs (n) sequences (n) sequences (%) OTUs (n) sequences (n) sequences (%) OTUs (n)
EV-A CV-A16 365 880 18,3 199 291 124 18,8 19 58 344 13,3 19
CV-A5 163 623 8,2 333 103 424 6,7 14 32 404 7,4 14
EV-A119 72 236 3,6 138 41 054 2,7 6 11 098 2,5 6
CV-A2 30 844 1,5 93 16 641 1,1 4 5 222 1,2 4
CV-A4 25 517 1,3 145 14 866 1,0 4 2 474 0,6 4
CV-A12 18 355 0,9 14 7 576 0,5 3 1 980 0,5 3
EV-A76 9 516 0,5 8 8 215 0,5 1 2 217 0,5 1
CV-A6 703 0,0 14 - - - - - -
EV-A89 676 0,0 4 529 0,0 1 276 0,1 1
CV-A14 490 0,0 11 - - - - - -
CV-A8 252 0,0 4 - - - - - -
EV-A71 62 0,0 5 - - - - - -
EV-A90 22 0,0 2 - - - - - -
total EV-A 688 176 34,4 970 483 429 31,3 52 114 015 26,0 52
EV-B CV-B5 705 235 35,2 868 606 460 39,2 43 192 616 43,9 43
E#9 72 306 3,6 89 56 796 3,7 7 17 021 3,9 7
E#33 46 597 2,3 24 45 525 2,9 4 13 081 3,0 4
CV-B2 36 093 1,8 43 26 971 1,7 5 8 582 2,0 5
E#11 33 361 1,7 72 23 125 1,5 3 5 475 1,2 3
E#6 22 469 1,1 17 19 269 1,2 1 3 875 0,9 1
E#14 21 476 1,1 23 20 180 1,3 4 8 843 2,0 4
CV-A9 20 377 1,0 77 4 774 0,3 6 1 831 0,4 6
CV-B4 14 630 0,7 145 8 055 0,5 2 2 950 0,7 2
CV-B1 12 691 0,6 30 4 403 0,3 4 889 0,2 4
E#16 9 015 0,5 18 2 839 0,2 2 799 0,2 2
CV-B3 6 161 0,3 9 4 937 0,3 1 1 631 0,4 1
E#18 5 277 0,3 25 2 777 0,2 3 623 0,1 3
E#5 5 011 0,3 15 2 170 0,1 1 631 0,1 1
CV-B6 4 771 0,2 6 4 680 0,3 1 4 275 1,0 1
E#1 1 708 0,1 4 1 383 0,1 1 300 0,1 1
E#20 729 0,0 3 705 0,0 1 170 0,0 1
E#25 477 0,0 6 - - - - - -
E#21 80 0,0 3 - - - - - -
E#30 50 0,0 3 - - - - - -
EV-B78 45 0,0 1 - - - - - -
E#3 38 0,0 2 - - - - - -
E#27 2 0,0 1 - - - - - -
total EV-B 1 018 599 50,9 1484 835 049 54,0 89 263 592 60,1 89
EV-C CV-A11 136 481 6,8 186 116 318 7,5 13 27 133 6,2 13
CV-A22 79 259 4,0 72 56 409 3,6 5 15 980 3,6 5
EV-C109 20 189 1,0 65 9 992 0,6 9 2 929 0,7 9
EV-C99 20 085 1,0 52 11 907 0,8 3 8 543 1,9 3
CV-A1 15 606 0,8 32 14 636 0,9 5 3 140 0,7 5
CV-A13 10 597 0,5 15 7 089 0,5 2 1 891 0,4 2
CV-A20 10 133 0,5 5 10 036 0,6 1 931 0,2 1
CV-A24 1 909 0,1 7 1 776 0,1 1 596 0,1 1
EV-C116 122 0,0 6 - - - - - -
Sabin-like-PV-1 16 0,0 1 - - - - - -
EV-C105 4 0,0 1 - - - - - -
CV-A19 3 0,0 1 - - - - - -
total EV-C 294 404 14,7 443 228 163 14,8 39 61 143 13,9 39
total EV 2 001 179 100,0 2897 1 546 641 100,0 180 438 750 100,0 180
Table 2
Clinical manifestations in the 130 hospitalized patients from October 2014 to
October 2015.
Symptoms Patients (n)
meningitis/neurological disease 52
infection in pregnant women and neonates 27
respiratory infection 23
febrile syndrome 12
myocarditis/pericarditis 4
examination for international adoption dossier 4
hand foot and mouth disease 2
diarrhea 2
not speciﬁed 4
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detected in patients clustered with OTUs (29/30, 97%) and one
major genetic cluster included OTUs collected in MarcheOctober
2015 and clinical sequences detected in AprileSeptember 2015.
One OTU detected in December 2014 only in wastewater was
genetically distant from all other sequences and was identiﬁed as
CV-B5 genogroup A by phylogenetic analysis (data not shown).
3.5. Temporal dynamics of viral diversity
The temporal distribution was performed for wastewater sam-
ples after normalisation of data and for clinical data using only local
infection in Clermont-Ferrand city. On the basis of the viral di-
versity observed, distinct patterns deﬁning four successive periods
were distinguished (Fig. 3). Between 28 October, 2014 and 3 March
2015, half of the viral sequences (50.5%) in wastewater samples
were assigned to types of the EV-A species. The samples contained
a range of 6e12 EV types, of which CV-A16 was predominant (35.2%
of the total sequences collected over the period). During the same
period, the viral sequences assigned to the EV-C species repre-
sented 27.5% of the total sequences. CV-A11 (15.6%) and CV-A22
(7.3%) were, respectively, the second and third most frequent
types. The EV-B species accounted for 22% of sequences, and the
most frequent types were E#33 (6.3%), CV-B2 (5.2%), and CV-B5
(3.3%). The ﬁrst CV-B5 detected in December 2014 was identiﬁed
as belonging to genogroup A while the following sequences
detected during this period and after were identiﬁed as belonging
to genogroup B.
The total viral load determined in the wastewater samples
during the four months was the lowest of the whole study period
with a mean 1,057 (range 102e1,678) viral genome copies/mL.
Clinical surveillance detected few EV infection cases except in
October and November 2014, twomonths marked by 17 respiratory
infections associated with EV-D68. CV-A16, the predominant EV
type in wastewater, was associated with no clinical cases. EV-C109
was associated with two respiratory infections and was detected in
wastewater.
During the second period, 16 March 2015 to 18 August 2015, the
CV-B5 sequences accounted for 77.1% of the total sequences and
ranged between 40% in a sample collected in May to 100% in a
sample collected in June. With 9.1% of the total viral sequences, CV-
A5 was the second most frequent type. The total viral load in
wastewater was 4,072 (range 290e4072) genome copies/mL. The
seasonal peak of clinical EV infections occurred during this second
period, in July 2015 (n¼ 56/130 cases, 43%). CV-B5 was the most
frequent type identiﬁed in patients (n¼ 24/56). Environmental
surveillance detected CV-B5 in March 2015 before the ﬁrst clinical
case in May 2015 and the summer meningitis outbreak in July.
During this period, 16 other EV types were also associated with
clinical cases and assigned to three EV species (B, n¼ 11, A, n¼ 4
and C, n¼ 1), but only half were detected in wastewater.
During the third period (September 2015), the mean viral load
was the highest determined over the year: 17,046 (range
2769e17046) copies/mL. The proportion of all the EV-B types,
including CV-B5, dropped to 64% of the total number of sequences.
Two other EV types, EV-C99 and CV-A22, accounted for 21.4% of the
total number of sequences. The number of clinical cases dropped to
10, 9 of which were associated with 5 types of EV-B species and 1
with CV-A6 (A species).
The total viral load (mean 2,107 [range 138e4075] genome
copies/mL) decreased over the fourth period, from 14 Octobere26
October 2015, and the distribution of EV types shifted again with
89.7% and 10.3% of sequences being assigned to EV species B and A,
respectively. CV-B5 was once again predominant in wastewater
(74.8% of viral sequences) while the number of clinical cases
remained low.
4. Discussion
This one-year pilot study to analyse wastewater sampled from a
Table 3
EV types identiﬁed in patients.
Species Types Patients (n)
EV-A CV-A4 4
CV-A6 4
CV-A2 3
CV-A5 1
CV-A8 1
EV-A71 1
EV-A120 1
EV-B CV-B5 30
E#25 8
E#18 7
E#5 6
E#6 6
E#7 6
E#11 6
E#16 4
CV-B3 3
E#9 3
E#13 2
E#21 2
CV-A9 1
CV-B1 1
CV-B4 1
EV-C EV-C109 2
CV-A13 1
EV-C99 1
EV-D EV-D68 17
NT 8
Fig. 1. Comparison of EV types detected by environmental surveillance in
Clermont-Ferrand (France) and by clinical surveillance in Clermont-Ferrand and
nationwide during the period 2014-2015.
The 48 EV types detected in the WWTP and types associated with patient hospitali-
zation in Clermont-Ferrand (n¼ 26) and France (n¼ 45) were compared and repre-
sented in a Venn diagram. Types in the intersection were detected by both surveillance
systems. EV-A species is shown in blue, EV-B species in red, EV-C species in green and
EV-D species in black.
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WWTP serving an urban community showed a highly dynamic co-
circulation of 48 EV types assigned to the taxonomic species A, B,
and C. Our results were consistent with those of a previous Amer-
ican study (Brinkman et al., 2017) that described a similar seasonal
distribution of EV species with an alternative predominance of EV-
A and EV-B, a major peak of EV-B during summer and fall and the
circulation of EV-C throughout the year. Unlike in our study, the
highest viral concentration in the sewage from the two WWTP
analysed was observed in July. To our knowledge, our study yields
the ﬁrst environmental and clinical data on the surveillance of non-
polio EV infections without cell culture bias concomitantly ob-
tained in a same urban population. The results showed the con-
sistency between the two surveillance systems: 22/26 EV types
identiﬁed in patients referred to the teaching hospital serving the
Fig. 2. Phylogenetic network of EV.
All EV types detected during the 2014e2015 study period are represented in phylogenetic networks for species A (A), B (B) and C (C). Strains detected in wastewater are in green and
clinical strains in red. Networks were built with Bionumerics software and maximum parsimony methods. Strains with less than 2% nucleotide differences were grouped into a
single sphere with a diameter proportional to the number of strains inside. For CV-B5, the two genogroups A and B, as deﬁned in a previous study (Henquell et al., 2013), are
indicated.
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population under study were also detected in wastewater moni-
toring. There were close phylogenetic relationships between virus
sequences detected in patients and wastewater. Yet, analysis of the
wastewater showed that EVs associated with community-acquired
infections in the urban population were much more diverse than
those associated with infections reported in the clinical setting
during the same period. The net number of EV types (intertype
diversity) was higher in the whole urban population than in
patients. Notably, the intertype diversity within the urban popu-
lation was actually similar to that reported in patients admitted to
hospitals nationwide during the same period. These ﬁndings sup-
port the conclusion that UDS with a multiplexed amplicon
approach can be used in raw urban wastewater to investigate the
ecology and transmission of EVs and assess the burden of these
enteric viruses in the general population.
The epidemiology of EV infections in 2014e2015 was marked by
Fig. 3. Quantity and diversity of EVs detected in the Clermont-Ferrand area over one year by the two surveillance systems.
(A) Relative abundance of the 33 conserved EV types detected in the WWTP of Clermont-Ferrand during 2014e2015 are given for each sample.(B) The quantity of EV expressed as
genome copies/mL. of WWTP water was determined in a previous study (Bisseux et al., 2018).(C) The diversity of EV types associated with patient hospitalization occurring in the
same city in the same period is represented for every two weeks preceding the mentioned date.
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the epidemic circulation of CV-B5, which accounted for 44% of the
sequences inwastewater and 28.5% (15/52) of meningitis cases. The
abrupt upsurge of CV-B5 was clearly identiﬁed in March 2015 by
wastewater analysis. The large circulation of CV-B5 was also
observed by the national network for EV surveillance, which
recorded this virus type as the second most frequent in France in
2015. Ten other EV-B typeswere co-detectedwith CV-B5 during the
winter 2014-2015 by environmental surveillance, notably E#11 (3%
of all sequences over the winter) and E#6 (2.4%). These viruses
were also detected during the meningitis outbreak in the summer.
In contrast, EV types E#33 (6.3%) and CV-B2 (5.2%) were only
detected in wastewater. Accordingly, the winter pattern of EV di-
versity in wastewater was not completely predictive of the pattern
during the following seasonal outbreak. Longer follow-up studies
includingWWTPs serving distinct urban communities are required
to provide a complete description of viral circulation dynamics.
Striking differences in the distribution pattern of EV-A and EV-C
types were also observed. Few infections associated with EV-A
types required hospitalization but the viruses circulated widely in
the community (26% of reads in wastewater), indicating that most
infected individuals had subclinical infections or self-limited ill-
nesses managed in ambulatory settings. CV-A16 is an example in
this respect. Conversely, while CV-A6 accounted for 0.03% reads in
wastewater, the virus was detected in four patients reported with
meningitis, myocarditis, and HFMD (including a case of atypical
HFMD clinical presentation). Our data are consistent with the
emergence of CV-A6 as a cause of worldwide disease concern (Bian
et al., 2015). Environmental and clinical surveillance revealed the
unexpected epidemiologic pattern of the EV-C types: large circu-
lation in the urban community and few disease cases (Apostol et al.,
2012; Benschop et al., 2017; Harvala et al., 2014). All the three EV-C
types identiﬁed in patients were traced back to wastewater. EV-
C109 was detected in two patients referred for respiratory dis-
eases and clustered close to viruses in wastewater. In contrast, CV-
A13 and EV-C99 detected in the stools of two adopted children and
in wastewater did not cluster.
Based on the structure of the sequence database and phyloge-
netic techniques used in our study, the sequence assignment rate
was high (99.6%) and enabled us to detect less abundant viruses.
Two EV types with direct public health relevance (EV-A71 and PV-1
Sabin) were detected in wastewater and identiﬁed down to the
strain level by analysis of sequence data. The low nucleotide vari-
ation in the wastewater PV-1 sequence compared with that of the
vaccine strain suggested no or limited circulation in the population.
Our French data are consistent with earlier results from the United
States and other European countries showing the importation of
vaccine PV strains into polio-free countries (Benschop et al., 2017;
Delogu et al., 2018). The ﬁndings clearly show the need to maintain
a high immunization coverage to avoid the occurrence of an
outbreak associated with the circulation of vaccine-derived polio-
viruses (VDPV), as reported in 2015 in Ukraine (Khetsuriani et al.,
2017). CV-A11 and CV-A22 were among the ﬁve most abundant
types in this study. These unexpectedly prevalent non-polio EV-C
types could be a gene reservoir for the emergence of recombinant
VDPV (Bessaud et al., 2011). We also evidenced the circulation of
rare EV-A (eg -A76, -A89), EV-B (eg -B78) and EV-C (eg -C105, -C116)
types previously unreported in the French population and for
which few epidemiological and genomic data are available. Notably,
our environmental surveillance identiﬁed ‘new’ EV-C types asso-
ciated with severe respiratory diseases and neurological disease
conditions, whose detection in the faeces was considered to be
difﬁcult (Holm-Hansen et al., 2016). Our ﬁndings suggest that the
circulation of these viruses in the community could be higher than
anticipated from the number of reported clinical infections and are
consistent with suggestions to enhance the surveillance of EV-C
species in respiratory specimens (Barnadas et al., 2017; Van Leer-
Buter et al., 2016).
Our study has two limitations. First, although the pan-EV
primers used included a high number of degenerate positions,
variations in the levels of PCR ampliﬁcation exist among EV types
and could explain why we did not detect EV-D68. This virus was
previously detected, however, by type-speciﬁc ampliﬁcation,
conﬁrmed by direct Sanger sequencing in 7/27 samples (Bisseux
et al., 2018). Second, we showed that incorrect assignment of
reads caused the random spread of signals within multiplexed
samples and artiﬁcially inﬂated the diversity detected in each
sample. This bias, referred to as mistagging (Esling et al., 2015) or
tag jump (Schnell et al., 2015), has been rarely documented and
taken into account in UDS analyses despite its critical impact on the
quality of data collected for ecological and epidemiological studies.
Minimising incorrect assignments and obtaining reliable results is a
real challenge for metabarcoding studies on Illumina sequencing
platforms. Strategies including controls must be incorporated into
the experimental design to perform sequence data ﬁltering (Esling
et al., 2015; Galan et al., 2016). Despite these limits, amplicon deep-
sequencing in wastewater for surveillance and epidemiological
studies clearly surpasses earlier techniques used in this ﬁeld. With
the implementation of robust quality controls, monitoring EVs in
wastewater can be implemented as a supplementary surveillance
system of the community at large to complement clinical
surveillance.
5. Conclusion
The combination of temporal wastewater sampling, efﬁcient
virus concentration from samples, analysis with amplicon deep-
sequencing and robust sequence assignment allow the detection
of a large array of EV types while avoiding the bias caused by cell
culture. Sustained environmental surveillance is an advanced
approach for a better understanding of the diversity of the EV
landscapewithin an urban community. The environmental ﬁndings
of this study show the circulation of clinically uncommon EVs,
including respiratory EV-C species strains and Sabin-like PV-1, and
provide a powerful complement to the clinical data.
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